Literature DB >> 22446046

Novel in-frame deletion mutation in FLCN gene in a Korean family with recurrent primary spontaneous pneumothorax.

Juwon Kim1, Jong-Ha Yoo, Du-Young Kang, Nam Joon Cho, Kyung-A Lee.   

Abstract

Birt-Hogg-Dubé syndrome (BHDS) is an autosomal dominant disease presenting with skin fibrofolliculomas, pulmonary cysts, primary spontaneous pneumothorax (PSP), and renal cancer. It is caused by germline mutations in the FLCN gene, which encodes folliculin. Here we report a novel in-frame deletion mutation p.F143del (c.427_429delTTC) in exon 6 of FLCN gene in the proband and her two sisters. The proband was a 40-year-old Korean woman who presented with right-sided pneumothorax and papular lesions on the face and neck area but without renal cancer. Her father also had a history of PSP and died of renal cancer at the age of 75. Her older sisters have been treated for recurrent PSP but did not have skin lesions suspicious of fibrofolliculoma. The relative expression of FLCN was significantly reduced in the proband and one of the sibling who was confirmed to have FLCN mutation. In-frame deletions in the FLCN gene have rarely been reported but have been shown to impose significant effect on protein stability of FLCN. Identification of a novel genotype in BHDS will provide clues to the phenotype-genotype relations and may aid in explaining the molecular pathogenesis of diseases related to FLCN mutation.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22446046     DOI: 10.1016/j.gene.2012.03.037

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  9 in total

1.  Clinical and genetic study of a large Chinese family presented with familial spontaneous pneumothorax.

Authors:  Huajie Xing; Yanguo Liu; Guanchao Jiang; Xiao Li; Yanyan Hou; Fan Yang; Jun Wang
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

2.  Recurrent renal cancer in Birt-Hogg-Dubé syndrome: A case report.

Authors:  Hammad Ather; Nida Zahid
Journal:  Int J Surg Case Rep       Date:  2017-11-28

3.  Birt-Hogg-Dubé Syndrome Manifesting as Spontaneous Pneumothorax: A Novel Mutation of the Folliculin Gene.

Authors:  Kyung Soo Kim; Hang Jun Choi; Woori Jang; Hyojin Chae; Myungshin Kim; Seok Whan Moon
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2017-10-05

4.  A Case of Birt-Hogg-Dubé (BHD) Syndrome Harboring a Novel Folliculin (FLCN) Gene Mutation.

Authors:  Takuro Yukawa; Takuya Fukazawa; Masakazu Yoshida; Ichiro Morita; Katsuya Kato; Yasumasa Monobe; Mitsuko Furuya; Yoshio Naomoto
Journal:  Am J Case Rep       Date:  2016-10-26

5.  Birt-Hogg-Dube syndrome prospectively detected by review of chest computed tomography scans.

Authors:  Hye Jung Park; Chul Hwan Park; Sang Eun Lee; Geun Dong Lee; Min Kwang Byun; Sungsoo Lee; Kyung-A Lee; Tae Hoon Kim; Seong Han Kim; Seo Yeon Yang; Hyung Jung Kim; Chul Min Ahn
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

6.  The clinical characteristics of East Asian patients with Birt-Hogg-Dubé syndrome.

Authors:  Ting Guo; Qinxue Shen; Ruoyun Ouyang; Min Song; Dandan Zong; Zhihui Shi; Yingjiao Long; Ping Chen; Hong Peng
Journal:  Ann Transl Med       Date:  2020-11

7.  Two Japanese cases of birt-hogg-dubé syndrome with pulmonary cysts, fibrofolliculomas, and renal cell carcinomas.

Authors:  Yukako Murakami; Mari Wataya-Kaneda; Mari Tanaka; Aya Takahashi; Akira Tsujimura; Koji Inoue; Norio Nonomura; Ichiro Katayama
Journal:  Case Rep Dermatol       Date:  2014-02-07

8.  Recurrent primary spontaneous pneumothorax in a large Chinese family: a clinical and genetic investigation.

Authors:  Chun-Ming Zheng; Xiao-Xing Hu; Yan-Li Gao; Jin-Bai Miao; Hui Li
Journal:  Chin Med J (Engl)       Date:  2019-10-20       Impact factor: 2.628

9.  A novel FLCN mutation in family members diagnosed with primary spontaneous pneumothorax.

Authors:  Burcu Genc Yavuz; Esra Guzel Tanoglu; Seda Salman Yılmaz; Sahin Colak
Journal:  Mol Genet Genomic Med       Date:  2019-10-18       Impact factor: 2.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.